Milestones, publications, and public proof points for SQK.
This section gathers investment announcements, product visibility, publications, and market signals that reinforce SQK’s QMedic-led commercialization strategy.
IBM Ventures invests in SQK
Public investment visibility that strengthens SQK’s ecosystem position and supports the broader QMedic-led commercialization narrative.
SuperQuantumStation recognized at CES 2024
External recognition that expanded market visibility and ecosystem reach for the SQK platform story.
QMedic public launch coverage
Public coverage of QMedic as SQK’s reliability-centered medical imaging platform for reconstruction, refinement, and quality-governed workflows.
QMedic IEEE publication
Research publication supporting QMedic’s imaging credibility and reinforcing SQK’s trust-centered product positioning.
Qukkos IEEE publication
Publication supporting SQK’s orchestration and hybrid execution narrative across quantum, classical, and HPC environments.
